These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2359244)

  • 1. [Evaluation of blood loss volume and the degree of activity of nonspecific ulcerative colitis by using Cr51-labeled erythrocytes].
    Kirkin BV; Rumiantsev VG; Kabanova IN
    Khirurgiia (Mosk); 1990 Mar; (3):57-61. PubMed ID: 2359244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative determination of blood loss by means of 51 Cr-labeled erythrocytes in occult hemorrhages of the gastrointestinal tract].
    Koch VK; Konrad H; Krüger M
    Z Gesamte Inn Med; 1976 Jun; 31(11):382-6. PubMed ID: 1085532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cr51: its use in the detection of blood in stools in the neonatal period].
    Cléa Rodrígues L; Flavio A C V; Victórico M
    Bol Med Hosp Infant Mex; 1977; 34(5):1067-71. PubMed ID: 303108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential error in the quantitation of fecal blood loss: concise communication.
    Chafetz N; Taylor A; Schleif A; Verba J; Hooser CW
    J Nucl Med; 1976 Dec; 17(12):1053-4. PubMed ID: 1086891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Method of double Fe59 and Cr51 labeling of erythrocytes in clinico-hematological studies].
    Sakhibov IaD
    Med Radiol (Mosk); 1973 Aug; 18(8):6-11. PubMed ID: 4545330
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correlations between parameters characterizing the volume and number of erythrocytes and platelets in human blood].
    Matiushichev VB; Shamratova VG; Khidiiatov II
    Fiziol Cheloveka; 2004; 30(3):136-9. PubMed ID: 15344719
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of intestinal blood losses in full-term infants].
    Cléa Rodrigues L; Flavio A C V; Victorio M
    Bol Med Hosp Infant Mex; 1977; 34(5):1081-7. PubMed ID: 303109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of gastrointestinal bleeding using Cr51-labeled red blood cells.
    IZAK G; STEIN Y; KARSHAI A
    Am J Dig Dis; 1960 Jan; 5():24-31. PubMed ID: 14406189
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of occult gastrointestinal bleeding in celiac disease.
    Mant MJ; Bain VG; Maguire CG; Murland K; Yacyshyn BR
    Clin Gastroenterol Hepatol; 2006 Apr; 4(4):451-4. PubMed ID: 16616349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cell volume determination using a stable isotope of chromium.
    Silver HM; Seebeck MA; Cowett RM; Patterson KY; Veillon C
    J Soc Gynecol Investig; 1997; 4(5):254-8. PubMed ID: 9360230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative determination of bleeding in ulcero-hemorrhagic colitis using the method of Cr-51 labeling of erythrocytes].
    Holub A; Rymkiewicz K
    Pol Tyg Lek; 1966 Aug; 21(32):1226-8. PubMed ID: 5298570
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatic changes in patients with nonspecific ulcerative colitis].
    Pontes RM; Muarrek FJ; Strauss E; Guembarowski AM
    Arq Gastroenterol; 1995; 32(2):48-53. PubMed ID: 8540801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
    Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis.
    Shimada M; Iwase H; Tsuzuki T; Hirashima N; Kobayashi K; Hibino Y; Watanabe H; Ryuge N; Ando T; Goto H; Yagi Y; Tsujikawa T; Andoh A
    Ther Apher Dial; 2008 Oct; 12(5):368-73. PubMed ID: 18937719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-loss studies for new non-steroidal anti-inflammatory drugs.
    Mitchell H; Barraclough D; Muirden KD
    Med J Aust; 1982 Apr; 1(8):328. PubMed ID: 6979672
    [No Abstract]   [Full Text] [Related]  

  • 17. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should whole-body red cell mass be measured or calculated?
    Balga I; Solenthaler M; Furlan M
    Blood Cells Mol Dis; 2000 Feb; 26(1):25-31; discussion 32-6. PubMed ID: 10772873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood volume determinations with radioactive chromium (Cr51) labeled erythrocytes; feasibility of routine total red blood cell volume determinations in a general hospital.
    MEYER LM
    J Am Med Assoc; 1956 Apr; 160(15):1312-5. PubMed ID: 13306548
    [No Abstract]   [Full Text] [Related]  

  • 20. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.